288 related articles for article (PubMed ID: 26865388)
21. Netherton syndrome in one Chinese adult with a novel mutation in the SPINK5 gene and immunohistochemical studies of LEKTI.
Xi-Bao Z; San-Quan Z; Yu-Qing H; Yu-Wu L; Quan L; Chang-Xing L
Indian J Dermatol; 2012 Jul; 57(4):265-8. PubMed ID: 22837558
[TBL] [Abstract][Full Text] [Related]
22. [A lethal variant of Netherton syndrome in a large inbred family].
Capri Y; Vanlieferinghen P; Boeuf B; Dechelotte P; Hovnanian A; Lecomte B
Arch Pediatr; 2011 Mar; 18(3):294-8. PubMed ID: 21255986
[TBL] [Abstract][Full Text] [Related]
23. Ichthyosis Linearis Circumflexa as the Only Clinical Manifestation of Netherton Syndrome.
Guerra L; Fortugno P; Pedicelli C; Mazzanti C; Proto V; Zambruno G; Castiglia D
Acta Derm Venereol; 2015 Jul; 95(6):720-4. PubMed ID: 25710899
[TBL] [Abstract][Full Text] [Related]
24. Clinical and genetic characterization of Netherton syndrome due to SPINK5 founder variant in Latvian population.
Nartisa I; Kirsteina R; Neiburga KD; Zigure S; Ozola L; Grantina I; Micule I; Murmane D; Slisere B; Gailite L; Vilne B; Rots D; Taurina G; Kurjane N
Pediatr Allergy Immunol; 2023 Apr; 34(4):e13937. PubMed ID: 37102386
[TBL] [Abstract][Full Text] [Related]
25. Lethal Netherton syndrome due to homozygous p.Arg371X mutation in SPINK5.
Diociaiuti A; Castiglia D; Fortugno P; Bartuli A; Pascucci M; Zambruno G; El Hachem M
Pediatr Dermatol; 2013; 30(4):e65-7. PubMed ID: 23331056
[TBL] [Abstract][Full Text] [Related]
26. SPINK5 knockdown in organotypic human skin culture as a model system for Netherton syndrome: effect of genetic inhibition of serine proteases kallikrein 5 and kallikrein 7.
Wang S; Olt S; Schoefmann N; Stuetz A; Winiski A; Wolff-Winiski B
Exp Dermatol; 2014 Jul; 23(7):524-6. PubMed ID: 24848304
[TBL] [Abstract][Full Text] [Related]
27. A new SPINK5 donor splice site mutation in siblings with Netherton syndrome.
Tüysüz B; Ojalvo D; Mat C; Zambruno G; Covaciu C; Castiglia D; D'Alessio M
Acta Derm Venereol; 2010; 90(1):95-6. PubMed ID: 20107740
[No Abstract] [Full Text] [Related]
28. Par2 inactivation inhibits early production of TSLP, but not cutaneous inflammation, in Netherton syndrome adult mouse model.
Briot A; Lacroix M; Robin A; Steinhoff M; Deraison C; Hovnanian A
J Invest Dermatol; 2010 Dec; 130(12):2736-42. PubMed ID: 20703245
[TBL] [Abstract][Full Text] [Related]
29. Establishment of an induced pluripotent stem cell line (SAHGMUi001-A) from a patient with Netherton syndrome carrying SPINK5 mutation.
Xu M; Wang L; Yin J; Xiong J; Guo Q; Yang W
Stem Cell Res; 2021 Mar; 51():102213. PubMed ID: 33556917
[TBL] [Abstract][Full Text] [Related]
30. Establishment of a mouse model of Netherton syndrome based on CRISPR/Cas9 technology.
Guo JZ; Su J; Dai H; Wang XY; Wu WB; Chen T; Zhang J; Wang WH
Eur J Dermatol; 2022 Jul; 32(4):459-463. PubMed ID: 36301754
[TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of a series of Israeli families with Comèl-Netherton syndrome.
Israeli S; Sarig O; Garty BZ; Indelman M; Bergman R; Sprecher E; Goldberg I
Dermatology; 2014; 228(2):183-8. PubMed ID: 24577329
[TBL] [Abstract][Full Text] [Related]
32. A compound heterozygous mutation of the SPINK5 gene in a Taiwanese boy with Netherton syndrome.
Chao SC; Tsai YM; Lee JY
J Formos Med Assoc; 2003 Jun; 102(6):418-23. PubMed ID: 12923596
[TBL] [Abstract][Full Text] [Related]
33. Skin Biopsy in Netherton Syndrome: A Histological Review of a Large Series and New Findings.
Leclerc-Mercier S; Bodemer C; Furio L; Hadj-Rabia S; de Peufeilhoux L; Weibel L; Bursztejn AC; Bourrat E; Ortonne N; Molina TJ; Hovnanian A; Fraitag S
Am J Dermatopathol; 2016 Feb; 38(2):83-91. PubMed ID: 26825155
[TBL] [Abstract][Full Text] [Related]
34. A novel mutation in
Wang Y; Song H; Yu L; Wu N; Zheng X; Liang B; Wang P
Front Genet; 2022; 13():943264. PubMed ID: 36159989
[TBL] [Abstract][Full Text] [Related]
35. A novel SPINK5 mutation and successful subcutaneous immunoglobulin replacement therapy in a child with Netherton syndrome.
Zelieskova M; Banovcin P; Kozar M; Kozarova A; Nudzajova Z; Jesenak M
Pediatr Dermatol; 2020 Nov; 37(6):1202-1204. PubMed ID: 32767583
[TBL] [Abstract][Full Text] [Related]
36. Netherton syndrome and its multifaceted defective protein LEKTI.
D'Alessio M; Fortugno P; Zambruno G; Hovnanian A
G Ital Dermatol Venereol; 2013 Feb; 148(1):37-51. PubMed ID: 23407075
[TBL] [Abstract][Full Text] [Related]
37. Severe lethal phenotype of a Japanese case of Netherton syndrome with homozygous founder mutations of SPINK5 c.375_376delAT.
Itoh K; Kako T; Suzuki N; Sakurai N; Sugiyama K; Yamanishi K
J Dermatol; 2015 Dec; 42(12):1212-4. PubMed ID: 26365906
[No Abstract] [Full Text] [Related]
38. Netherton syndrome caused by compound heterozygous mutation, c.80A>G mutation in SPINK5 and large-sized genomic deletion mutation, and successful treatment of intravenous immunoglobulin.
Zhang Z; Pan C; Wei R; Li H; Yang Y; Chen J; Li M; Yao Z
Mol Genet Genomic Med; 2021 Mar; 9(3):e1600. PubMed ID: 33452875
[TBL] [Abstract][Full Text] [Related]
39. A New Splice-site Mutation of
Erden E; Ceylan AC; Emre S
Balkan J Med Genet; 2020 Jun; 23(1):91-94. PubMed ID: 32953415
[TBL] [Abstract][Full Text] [Related]
40. Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses.
Barbieux C; Bonnet des Claustres M; Fahrner M; Petrova E; Tsoi LC; Gouin O; Leturcq F; Nicaise-Roland P; Bole C; Béziat V; Bourrat E; Schilling O; Gudjonsson JE; Hovnanian A
J Allergy Clin Immunol; 2022 Apr; 149(4):1358-1372. PubMed ID: 34543653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
